Seroconversion of type B to O erythrocytes using recombinant Glycine max alpha-D-galactosidase. 1998

N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
Department of Biology, University of Missouri, Columbia 65212, USA.

Recombinant alpha-D-galactosidase (rGal) from soybean (Glycine max) hydrolyzed the immunodominant alpha-D-galactose residue from the B epitope of red blood cells. This converted type B erythrocytes to type O which are "universally" transfusable. Type B red blood cells were obtained from four different donors and enzymatically converted. Cell function parameters, including red cell indices, pH, methemoglobin, carboxyhemoglobin, osmotic fragility, hemolysis, 2,3-diphosphoglycerate, cholinesterase, ATP, and antigen typing of treated cells were compared to controls. These pilot studies indicate that rGal could have potential biotechnical application in the production of universally transfusable red blood cells.

UI MeSH Term Description Entries
D009996 Osmotic Fragility RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst. Saline Fragility,Fragility, Osmotic,Fragility, Saline
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase
D004909 Erythrocyte Indices ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC). Erythrocyte Hemoglobin, Mean Cell,Erythrocyte Size Determination,Erythrocyte Volume, Mean Cell,Hemoglobin, Erythrocyte, Mean Cell,Mean Corpuscular Volume,Red Cell Indices,Erythrocyte Diameter,Erythrocyte Index,Erythrocyte Indexes,Erythrocyte Thickness,Mean Cell Hemoglobin Concentration,Mean Cell Volume,Mean Corpuscular Hemoglobin,Mean Corpuscular Hemoglobulin Concentration,Red Cell Distribution Width,Red Cell Index,Red Cell Indexes,Cell Volumes, Mean,Corpuscular Volumes, Mean,Determination, Erythrocyte Size,Determinations, Erythrocyte Size,Diameter, Erythrocyte,Diameters, Erythrocyte,Erythrocyte Diameters,Erythrocyte Size Determinations,Hemoglobin, Mean Corpuscular,Hemoglobins, Mean Corpuscular,Index, Erythrocyte,Index, Red Cell,Indexes, Erythrocyte,Indexes, Red Cell,Indices, Erythrocyte,Indices, Red Cell,Mean Cell Volumes,Mean Corpuscular Hemoglobins,Mean Corpuscular Volumes,Size Determination, Erythrocyte,Size Determinations, Erythrocyte,Thickness, Erythrocyte,Volume, Mean Cell,Volume, Mean Corpuscular,Volumes, Mean Cell,Volumes, Mean Corpuscular
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005690 Galactose An aldohexose that occurs naturally in the D-form in lactose, cerebrosides, gangliosides, and mucoproteins. Deficiency of galactosyl-1-phosphate uridyltransferase (GALACTOSE-1-PHOSPHATE URIDYL-TRANSFERASE DEFICIENCY DISEASE) causes an error in galactose metabolism called GALACTOSEMIA, resulting in elevations of galactose in the blood. D-Galactose,Galactopyranose,Galactopyranoside,D Galactose
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000017 ABO Blood-Group System The major human blood type system which depends on the presence or absence of two antigens A and B. Type O occurs when neither A nor B is present and AB when both are present. A and B are genetic factors that determine the presence of enzymes for the synthesis of certain glycoproteins mainly in the red cell membrane. ABH Blood Group,ABO Blood Group,ABO Factors,Blood Group H Type 1 Antigen,H Blood Group,H Blood Group System,ABO Blood Group System,Blood Group, ABH,Blood Group, ABO,Blood Group, H,Blood-Group System, ABO,Factors, ABO,System, ABO Blood-Group

Related Publications

N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
January 1995, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
March 1996, Archives of biochemistry and biophysics,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
June 1996, Biochemistry and molecular biology international,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
July 2007, Chinese medical journal,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
April 2011, Zhongguo shi yan xue ye xue za zhi,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
January 1990, Biotechnology and bioengineering,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
November 1975, Israel journal of medical sciences,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
November 1976, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
March 1996, Clinica chimica acta; international journal of clinical chemistry,
N C Vosnidou, and S A Johnson, and M M Mitra, and D C Wells, and C Q Li, and M L Evans, and M A Harmata, and J C Walker, and D S Smith
October 1993, Carbohydrate research,
Copied contents to your clipboard!